AstraZeneca cancer drug carries toxic risks: FDA
An experimental drug developed by AstraZeneca to treat a rare form of thyroid cancer carries "substantial toxicity" risks, the US Food and Drug Administration warned Tuesday.
Thirty-one percent of patients taking the drug, vandetanib, experienced serious side effects compared to 13 percent who did when taking a placebo.
Side effects included a potentially dangerous skin rash known as Stevens-Johnson syndrome, strokes and lung disease.
Many patients involved in studies also had to switch to lower doses, the FDA said in a report ahead of a December 2 meeting of outside experts to discuss the findings and recommend whether the drug should come to market.
Eighty percent of patients in a Phase II study that began with a 300-milligram dose of the drug "required a dose reduction or interruption."
A subsequent study that gave patients a 100-milligram dose saw 21 percent require dosage to be reduced or stopped.
"Given the substantial toxicity seen with vandetanib, should its indication be limited to patients with progressive, symptomatic medullary thyroid cancer?" the FDA asked. "Should additional doses of vandetanib be explored?"
The FDA does not have to follow the expert panel's recommendations but it often does.
AstraZeneca expects to have a decision by January on its new drug application for vandetanib in patients with medullary thyroid cancer, a relatively rare disease that typically carries lower survival rates than other forms of thyroid cancer.
Some 45,000 new cases are expected to be diagnosed this year in the United States.
The company says the drug works by slowing tumor growth.
Vandetanib was initially set to be a treatment for lung cancer but AstraZeneca withdrew its request for the drug to be put on the market for such use in 2009 after studies showed it failed to extend survival rates.
(c) 2010 AFP
-
From lemons to lemonade: Reaction uses carbon dioxide to make carbon-based semiconductor,
28 comments
-
Every black hole contains a new universe: A physicist presents a solution to present-day cosmic mysteries,
215 comments
-
New silicon memory chip developed,
16 comments
-
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments,
2 comments
-
SpaceX private rocket blasts off for space station (Update),
41 comments
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Researchers identify key brain cell in antidepressant action
(Medical Xpress) -- Antidepressant medications such as Prozac have helped improve mood and lessen anxiety in millions of people with major depression. But scientists know surprisingly little about how these drugs work.
Medicine & Health / Medical research
59 minutes ago |
not rated yet |
0
|
New prostate cancer screening guidelines face a tough sell, study suggests
(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...
1 hour ago |
not rated yet |
0
Questionable research practices surprisingly common
(Medical Xpress) -- Not all scientific misconduct is flat-out fraud. Much falls into the murkier realm of questionable research practices. A new study finds that in one field, psychology, these practices are surprisingly ...
Medicine & Health / Psychology & Psychiatry
56 minutes ago |
not rated yet |
0
|
Energy levels link sleep control mechanisms
Sleep, or lack of it, can determine level of cognitive performance which is linked with accidents as well as increased risk of serious health problems. Links between cell energy levels, gene transcription ...
Medicine & Health / Medical research
34 minutes ago |
not rated yet |
0
Researchers demonstrate possible primitive mechanism of chemical info self-replication
(Phys.org) -- When scientists think about the replication of information in chemistry, they usually have in mind something akin to what happens in living organisms when DNA gets copied: a double-stranded molecule ...
Looking out for the Myanmar snub-nosed monkey
A new genetic study has shed light on how the newly discovered Myanmar snub-nosed monkey evolved.
Alibaba.com $2.5B privatization bid approved
(AP) -- Chinese e-commerce firm Alibaba Group's $2.5 billion bid to take its Hong Kong-listed unit private was cleared Friday by minority shareholders, easing the way for CEO Jack Ma to gain more control over his company's ...
SKA super telescope to be built in Australia, South Africa
Australia and South Africa will share the location for the world's most powerful radio telescope, the Square Kilometre Array's scientific consortium announced on Friday.
Researchers successfully test solar desalination system for arid land agriculture
Ben-Gurion University of the Negev (BGU) researchers have created a man-made oasis in the desert with the successful application of a solar-powered desalination system that provides water for irrigation in arid regions. The ...
ESA: Unveiling Venus
With Venus about to get its day in the Sun very much literally the European Space Agency has assembled an excellent video about our planetary neighbor.